已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

内科学 cGMP特异性磷酸二酯酶5型
作者
Irwin Goldstein,Tom F. Lue,Harin Padma-Nathan,Raymond C. Rosen,William D. Steers,Pierre A. Wicker
出处
期刊:The New England Journal of Medicine [New England Journal of Medicine]
卷期号:338 (20): 1397-1404 被引量:1821
标识
DOI:10.1056/nejm199805143382001
摘要

BACKGROUND Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis [corrected] in the corpus cavernosum and therefore increases the penile response to sexual stimulation. We evaluated the efficacy and safety of sildenafil, administered as needed in two sequential double-blind studies of men with erectile dysfunction of organic, psychogenic, and mixed causes. METHODS In a 24-week dose-response study, 532 men were treated with oral sildenafil (25, 50, or 100 mg) or placebo. In a 12-week, flexible dose-escalation study, 329 different men were treated with sildenafil or placebo, with dose escalation to 100 mg based on efficacy and tolerance. After this dose-escalation study, 225 of the 329 men entered a 32-week, open-label extension study. We assessed efficacy according to the International Index of Erectile Function, a patient log, and a global-efficacy question. RESULTS In the dose-response study, increasing doses of sildenafil were associated with improved erectile function (P values for increases in scores for questions about achieving and maintaining erections were <0.001). For the men receiving 100 mg of sildenafil, the mean score for the question about achieving erections was 100 percent higher after treatment than at base line (4.0 vs. 2.0 of a possible score of 5). In the last four weeks of treatment in the dose-escalation study, 69 percent of all attempts at sexual intercourse were successful for the men receiving sildenafil, as compared with 22 percent for those receiving placebo (P<0.001). The mean numbers of successful attempts per month were 5.9 for the men receiving sildenafil and 1.5 for those receiving placebo (P<0.001). Headache, flushing, and dyspepsia were the most common adverse effects in the dose-escalation study, occurring in 6 percent to 18 percent of the men. Ninety-two percent of the men completed the 32-week extension study. CONCLUSIONS Oral sildenafil is an effective, well-tolerated treatment for men with erectile dysfunction.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI

祝大家在新的一年里科研腾飞
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MM完成签到 ,获得积分10
刚刚
hello发布了新的文献求助10
2秒前
凝凝完成签到 ,获得积分10
3秒前
万能图书馆应助星河采纳,获得10
3秒前
JamesPei应助ww采纳,获得10
5秒前
思源应助VELPRO采纳,获得10
7秒前
NexusExplorer应助JerryZ采纳,获得10
7秒前
科研通AI2S应助JerryZ采纳,获得10
7秒前
7秒前
hrzmlily完成签到,获得积分10
7秒前
鸿宇发布了新的文献求助30
8秒前
9秒前
举栗子完成签到 ,获得积分10
11秒前
yingna发布了新的文献求助10
13秒前
柠檬发布了新的文献求助10
13秒前
彭于晏应助科研通管家采纳,获得10
13秒前
NexusExplorer应助科研通管家采纳,获得10
14秒前
科研通AI2S应助科研通管家采纳,获得10
14秒前
英俊的铭应助科研通管家采纳,获得10
14秒前
hha完成签到,获得积分10
14秒前
嘻嘻尼88完成签到 ,获得积分10
14秒前
天边的云彩完成签到 ,获得积分10
15秒前
逝水无痕发布了新的文献求助10
15秒前
16秒前
17秒前
彩色的冬莲完成签到 ,获得积分10
19秒前
汪小白发布了新的文献求助10
19秒前
21秒前
英姑应助DE2022采纳,获得10
22秒前
Wei发布了新的文献求助20
22秒前
富裕山人完成签到 ,获得积分10
23秒前
25秒前
冯哒哒完成签到 ,获得积分10
25秒前
我是老大应助高兴紫寒采纳,获得10
29秒前
柠檬完成签到,获得积分20
30秒前
DDD发布了新的文献求助10
31秒前
菜吃饭发布了新的文献求助10
31秒前
32秒前
义气成风应助DE2022采纳,获得10
36秒前
闪闪落雁发布了新的文献求助20
37秒前
高分求助中
Востребованный временем 2500
The Three Stars Each: The Astrolabes and Related Texts 1500
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
Les Mantodea de Guyane 800
Mantids of the euro-mediterranean area 700
The Oxford Handbook of Educational Psychology 600
有EBL数据库的大佬进 Matrix Mathematics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 内科学 物理 纳米技术 计算机科学 遗传学 化学工程 基因 复合材料 免疫学 物理化学 细胞生物学 催化作用 病理
热门帖子
关注 科研通微信公众号,转发送积分 3413034
求助须知:如何正确求助?哪些是违规求助? 3015511
关于积分的说明 8870585
捐赠科研通 2703183
什么是DOI,文献DOI怎么找? 1482085
科研通“疑难数据库(出版商)”最低求助积分说明 685129
邀请新用户注册赠送积分活动 679909